Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) FCF Margin (2021 - 2025)

HeartSciences filings provide 5 years of FCF Margin readings, the most recent being 96497.15% for Q4 2025.

  • On a quarterly basis, FCF Margin changed N/A to 96497.15% in Q4 2025 year-over-year; TTM through Jan 2026 was 84569.42%, a 4452686.0% decrease, with the full-year FY2025 number at 170486.23%, down 13750429.0% from a year prior.
  • FCF Margin hit 96497.15% in Q4 2025 for HeartSciences, up from 102808.79% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 9587.0% in Q3 2021 to a low of 102808.79% in Q3 2025.
  • Median FCF Margin over the past 5 years was 35916.03% (2025), compared with a mean of 45853.2%.
  • Biggest five-year swings in FCF Margin: plummeted -4725534bps in 2022 and later skyrocketed 3813463bps in 2024.
  • HeartSciences' FCF Margin stood at 9587.0% in 2021, then plummeted by -493bps to 56842.34% in 2022, then skyrocketed by 55bps to 25388.18% in 2023, then skyrocketed by 43bps to 14352.14% in 2024, then plummeted by -572bps to 96497.15% in 2025.
  • The last three reported values for FCF Margin were 96497.15% (Q4 2025), 102808.79% (Q3 2025), and 36566.44% (Q2 2025) per Business Quant data.